Exploring the role of PARP1 inhibition in enhancing antibody–drug conjugate therapy for acute leukemias: insights from DNA damage response pathway interactionsAndrea Ghelli Luserna di Rorà, Giovanni Martinelli, Francesco Olimpico et al.|Journal of Translational Medicine|2024Cited by 5
PARP1 in melanoma: Mechanistic insights and implications for basic and clinical researchAndrea Marranci, Laura Poliseno, Luisa Maresca et al.|Cancer Letters|2025Cited by 3
Apcin-derived CDC20 inhibitors synergize with microtubule disruptors to induce mitotic catastrophe in acute leukemiasAndrea Marranci, G. Simonetti, Andrea Ghelli Luserna di Rorà et al.|Blood|2025Cited by 0